期刊文献+

药物综合治疗糖尿病肾病临床研究

Clinical Research on Drug Comprehensive Treatment of Diabetic Nephropathy
下载PDF
导出
摘要 目的探讨药物综合治疗糖尿病肾病的临床疗效和安全性,提高临床诊治效率。方法回顾性分析2008年4月至2011年4月我院采用中西医结合治疗方法进行治疗的86例糖尿病肾病患者的临床资料,并以同期采用单纯西医治疗的86例患者为对照组,比较2组患者治疗效果。结果观察组总有效率明显高于对照组,组间比较差异具有统计学意义(P<0.05);治疗组患者治疗后24h尿蛋白定量检测值明显降低,血黏稠度减低,总胆固醇减低,以上指标均优于对照组(P<0.05)。结论补肝益肾活血化瘀方药治疗糖尿病肾病具有调整脂代谢、减少蛋白尿、改善血黏度和延缓肾功能减退进程等作用。 Objective To investigate the treatment of diabetic nephropathy drug clinical efficacy and safety,improve the clinical diagnosis and treatment efficiency.Methods Retrospective analysis April 2008 to 2011 from April by combining traditional Chinese and western medicine treatment method for treatment of the diabetes nephrosis patient's 86 patients with clinical informalion,and using the same pure western treatment for 86 cases were group,rompared with two groups of patients therapeutic effect.Pesults The observation group total effectiveness significantly higher than those in the control group,between groups are statistically significant comparative differences (P〈0.05).The quantity of urine protein of 24 hours,plasma viscosity and total cholesterol decreased in the treatment group after 3 months,which was more obvious than that in the control group(P〈0.05).Conclusion The Chinese herbs of tonification liver and kidney and activating blood to remove stasis can decrease the quantity of urine protein,improve the plasma viscosity,adjust fat metabolism and delay the aggravation of the renal function.
作者 叶荣
出处 《中国卫生产业》 2011年第7期33-34,共2页 China Health Industry
关键词 糖尿病肾病 中西医结合 常规治疗 Diabetic nephropathy Integrated traditional and western medicine Conventional treatment
  • 相关文献

参考文献4

二级参考文献31

  • 1LIUBi-cheng XUYan MAKun-ling HUANGHai-quan YINLian-fang LIUDian-ge.Effects of irbesartan on the expression of matrix metalloproteinase-2/ tissue inhibitor of metalloproteinase-2 in streptozotocin-induced diabetic rat kidney[J].Chinese Medical Journal,2005(12):1040-1044. 被引量:7
  • 2李轶.尿微量白蛋白检测对糖尿病肾病早期诊断的意义[J].中国社区医师(医学专业),2005,7(22):82-82. 被引量:3
  • 3姚春艳 杨沆 邓光贵.尿微量清蛋白检测与糖尿病肾病.国外医学临床生物化学与检验学分册,2001,21(12):121-122.
  • 4Mogensen CI. Early glomerular hyperfiltration in insulin-depen- dentdiabetics(I) [J]. Scand J Clinlab Invest, 1996,46 (3) : 201-206.
  • 5The Diabetes Control and Complications Trail Research Group.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus[J].N Engl J Med,1993,329(14):977-986.
  • 6UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J].Lancet,1998,352(9131):837-853.
  • 7Hashimoto H,Kitagawa K,Hougaku H,et al.C-reactive protein is an independent predictor of the rate of increase in early carotid at herosclerosis[J].Circulation,2001,104 (1):63-67.
  • 8De Jager J,Dekker JM,Kooy A,et al.Endo the lial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes:the Hoorn study[J].Arterioscler Thromb Vasc Biol,2006,26(5):1086-1093.
  • 9Friedman AN,Hunsicker LG,Selhub J,et al.C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy[J].Kidney Int,2005,68 (2):773-778.
  • 10Chen S,Evans T,Deng D,et al.Hypeerhexo sem ia induced functional and structural changes in the kidneys:role of endothe lines[J].Nephron,2002,90(1):86-94.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部